Diagnosis

·MeSH: Disease

22 drugs in development·19 companies·1 clinical trial

Drug Pipeline by Phase

Approved(16)

Drug	Company
Alinity® family	ABBOTT LABORATORIES (ABT)
almotriptan malate	Mylan II B.V. (MYL)
atomoxetine	Teva Pharmaceutical Industries Limited (TEVA)
atomoxetine	Aptinyx Inc. (APTX)
atomoxetine	DR REDDYS LABORATORIES LTD (RDY)
bupropion	Design Therapeutics, Inc. (DSGN)
bupropion	Prestige Consumer Healthcare Inc. (PBH)
buspirone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
dextroamp saccharate	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
eletriptan hydro	Mylan II B.V. (MYL)
Galafold	AMICUS THERAPEUTICS, INC. (FOLD)
Ocular Lactoferrin (Lf)	AXIM BIOTECHNOLOGIES, INC. (AXIM)
sumatriptan	Mylan II B.V. (MYL)
sumatriptan	DR REDDYS LABORATORIES LTD (RDY)
supprelin la	Endo LP (NDOI)
trikafta	VERTEX PHARMACEUTICALS INC / MA (VRTX)

Phase 2(2)

Drug	Company
Oral versus topical antibioitics	UNITED THERAPEUTICS Corp (UTHR)
WIN378	Valneva SE (VALN)

Preclinical(2)

Drug	Company
matloc 2	MARIZYME, INC. (MRZM)
nu.q cancer	VOLITIONRX LTD (VNRX)

Unknown(2)

Drug	Company
Astellas theranostics collaboration	Actinium Pharmaceuticals, Inc. (ATNM)
Precise Liquid	MYRIAD GENETICS INC (MYGN)

BioSniper tracks 22 drugs in development for Diagnosis across 19 companies.

There are 1 clinical trial targeting Diagnosis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.